Table 1.
SGT category | Tpeak | Tmax | WR180 | WR540 | Absolute enhancement | Enhancement ratio |
---|---|---|---|---|---|---|
BNW | 191.84 ± 108.13 | 4.09 ± 186.77 | 0.67 ± 2.80% | 3.37 ± 8.22% | 7.45 ± 370.56 | 2.20 ± 0.85 |
Warthin | 37.00 ± 3.41 | 44.50 ± 6.02 | 28.20 ± 7.29% | 47.63 ± 15.92% | 7.25 ± 312.05 | 1.55 ± 0.74 |
Malignant | 82.80 ± 84.14 | 1.80 ± 203.10 | 11.86 ± 11.49% | 25.38 ± 18.52% | 8.33 ± 396.76 | 1.92 ± 0.92 |
BNW–Warthin | <0.005 | <0.005 | <0.005 | <0.005 | 0.96 | 0.90 |
BNW–malignant | 0.002 | 0.001 | <0.005 | <0.005 | 0.43 | 0.42 |
Warthin–malignant | 0.05 | 0.19 | <0.005 | <0.005 | 0.37 | 0.31 |
SGT, salivary gland tumour; WR, washout ratio.
p-value of each parameter for differentiation between tumour subtypes is given.